U.S., Jan. 16 -- ClinicalTrials.gov registry received information related to the study (NCT07343856) titled 'Long COVID Diagnostic Reactivity Assesment Test' on Dec. 24, 2025.
Brief Summary: This study is a diagnostic clinical investigation designed to evaluate bioelectrical response patterns assessed by electro-acupuncture-based medicament testing.
The method is used to identify individual bioelectrical reactivity associated with the presence and persistence of pathological factors and to assess patient-specific responses to tested medicinal substances.
The study involves a single-session, non-invasive diagnostic procedure without administration of pharmacological treatment. The primary objective is the methodological evaluation of the ...